ASK REDCHAT ANYTHING ABOUT OPKO HEALTH INC.
Opko Health Inc. (NASDAQ: OPK)
Listen to this Section
$1.42
-0.0450
(
-3.08% )
1.4M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| NGENLA® SomatrogonDetailsPediatric growth hormone deficiency |
Approved |
| Rayaldee (calcifediol ER capsules)DetailsChronic kidney disease |
Approved |
| OPK88003 (oxyntomodulin analog) (GLP-1R/GCGR agonist)DetailsType 2 diabetes |
Phase 2 |
| SAR441236DetailsHuman immunodeficiency virus |
Phase 1 |
| MDX2001 (Tetraspecific LASER)DetailsCancer, Solid tumor/s |
Phase 1 |
| RayaldeeDetailsCOVID-19 |
Failed |
Market Data
|
| Open |
$1.42 |
| Previous Close |
$1.46 |
| Volume |
1.4M |
| Market Cap |
$1.10B |
| Day Range |
$1.42 - $1.47 |
| 52 Week Range |
$0.98 - $1.60 |
| Shares Outstanding |
755.09M |
| Change % |
-3.08% |
| Net Change |
▼ -0.0450 |
| Insider Ownership |
0.19% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| IPO Year | 1995 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
9,808,207.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-11-13 |
Buy |
10000.00 |
Rubin Steven D |
| 2023-08-18 |
Buy |
1500.00 |
FROST PHILLIP MD ET AL |
| 2023-08-15 |
Buy |
9819.00 |
FROST PHILLIP MD ET AL |
| 2023-08-10 |
Buy |
5405.00 |
FROST PHILLIP MD ET AL |
| 2023-08-08 |
Buy |
100.00 |
FROST PHILLIP MD ET AL |